SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs >

Allergan (AGN)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 11/29/2017 7:42:34 AM - Followers: 9 - Board type: Free - Posts Today: 0
SureTrader
Interactive Brokers Advertisement
PostSubject
#138  Sticky Note Adverse ruling on Restasis patent in US District Court: DewDiligence 10/16/17 02:04:54 PM
#145   Maybe the reversal starts today T695 11/29/17 07:42:34 AM
#144   Why is this board not connected to the ticker?? T695 11/06/17 10:47:08 AM
#143   Transcript of AGN’s 3Q17 CC: DewDiligence 11/02/17 03:47:59 PM
#142   anyone looking to buy today? rcookr1 11/02/17 09:12:46 AM
#141   3Q17 worldwide Botox sales=$775M: #msg-135855769. DewDiligence 11/01/17 09:31:50 AM
#140   AGN 3Q17 CC slides: DewDiligence 11/01/17 08:35:46 AM
#139   $AGN - Allergan Was Correct To Fight The KarinCA 10/23/17 02:07:04 PM
#138   Adverse ruling on Restasis patent in US District Court: DewDiligence 10/16/17 02:04:54 PM
#137   AGN, PFE settle Restasis-patent litigation: #msg-135360904. DewDiligence 10/12/17 07:00:57 PM
#136   AGN authorizes $2B buyback and increased dividend: #msg-134875241. DewDiligence 09/25/17 10:03:39 AM
#135   AGN reports mixed phase-2b NASH data: DewDiligence 09/22/17 10:50:59 AM
#134   https://seekingalpha.com/article/4107923-amgen-allergan-avastin-biosimilar-appro Inoviorulez 09/19/17 06:50:06 PM
#133   AGN’s novel ploy to protect Restasis exclusivity: #msg-134477923. DewDiligence 09/08/17 12:52:50 PM
#132   AGN 2Q17 CC slides: DewDiligence 08/03/17 12:34:50 PM
#131   2Q17 Botox sales by category: #msg-133533732. DewDiligence 08/03/17 11:58:05 AM
#130   ODAC endorsed AMGN/AGN’s Avastin FoB by unanimous vote: DewDiligence 07/13/17 07:24:32 PM
#129   AGN 1Q17 items… DewDiligence 05/09/17 10:12:37 AM
#128   Does AGN have a way around the new hiwatt1959 04/23/17 07:33:44 PM
#127   NVS, AGN collaborate on phase-2b for NASH combo: #msg-130568056. DewDiligence 04/18/17 11:00:09 AM
#126   AGN moves Botox to phase-3 in depression despite DewDiligence 04/05/17 06:17:01 PM
#123   Why Kybella has disappointed: #msg-129497650. DewDiligence 03/14/17 11:41:00 AM
#122   AGN, EDIT ink drug-discovery collaboration for eye diseases: #msg-129491806. DewDiligence 03/14/17 09:29:49 AM
#121   FDA approves Noctiva for frequent nighttime urination: #msg-129243463. DewDiligence 03/06/17 10:39:48 AM
#120   4Q16 Botox sales: $729M, +14% YoY: #msg-128533148. DewDiligence 02/08/17 12:15:11 PM
#119   AGN 4Q16 items… DewDiligence 02/08/17 11:44:38 AM
#118   Option pricing suggest a move of ~$10 or nowlurking 02/07/17 10:33:43 AM
#117   Allergan $AGN valuation models shows 14% upside b4 ValueInvestor15 02/07/17 09:28:19 AM
#116   5 Manufacturing Stocks with 25% Upside Potential: AGN ValueInvestor15 01/04/17 03:17:26 PM
#115   AGN acquires (private) LifeCell for $2.9B cash: #msg-127307118. DewDiligence 12/20/16 09:59:16 AM
#114   Further discussion of Dry Eye Syndrome[DES]: north40000 12/12/16 02:50:21 PM
#113   IMO, both AGN and MYL will have difficulty north40000 12/08/16 08:59:14 PM
#112   MYL obtains IPRs on several Restatis patents: DewDiligence 12/08/16 07:43:50 PM
#111   Wow what a beating Picked up 200 shares will Tradescott818 11/04/16 05:26:22 PM
#110   AGN 3Q16 CC slides: DewDiligence 11/02/16 10:04:28 AM
#109   AGN announces $10B buyback authorization—and first-ever dividend (starting DewDiligence 11/02/16 08:41:41 AM
#107   AGN reports 3Q16 results—Botox leads the way: DewDiligence 11/02/16 08:15:50 AM
#106   AGN licenses AZN’s MEDI2070—an IL-23 inhibitor: #msg-125539596. DewDiligence 10/03/16 10:06:16 AM
#105   AGN CC slides: DewDiligence 09/21/16 08:27:36 AM
#104   AGN CC—today 8:30am ET—re acquisitions of TBRA (#msg-125266132) DewDiligence 09/21/16 07:01:22 AM
#102   2Q16 Botox sales $720M, +14% YoY: #msg-124379793. DewDiligence 08/11/16 11:55:27 AM
#101   AGN buys private glaucoma-device company for $95M: DewDiligence 08/11/16 11:54:04 AM
#100   AMGN/AGN report phase-3 data for Herceptin FoB: #msg-124404733. DewDiligence 08/09/16 10:43:23 AM
#99   FTC backs TEVA-AGN deal with conditions: #msg-124151534. DewDiligence 07/27/16 02:46:53 PM
#98   Botox global 1Q16 sales $638M, +17% YoY in DewDiligence 05/10/16 08:49:36 AM
#97   AGN 1Q16 CC slides: DewDiligence 05/10/16 08:31:29 AM
#96   Thanks, I hadn't heard that either, but realize BeingReal 04/26/16 09:18:56 PM
#95   There's some fear (mostly misguided, IMO) that the DewDiligence 04/26/16 04:29:50 PM
#94   That's probably why I didn't hear about it. BeingReal 04/26/16 03:33:41 PM
#93   I like the Topokine deal, but it's hardly DewDiligence 04/26/16 03:29:56 PM
#92   Maybe I read this wrong. I haven't BeingReal 04/26/16 03:28:41 PM
PostSubject